Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Incannex Healthcare (IXHL) over the last 3 years, with Q4 2025 value amounting to -$65.9 million.

  • Incannex Healthcare's Depreciation and Depletion rose 12.73% to -$65.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $143.0 billion, marking a year-over-year increase of 3883.46%. This contributed to the annual value of $143.0 billion for FY2025, which is 3883.5% up from last year.
  • Per Incannex Healthcare's latest filing, its Depreciation and Depletion stood at -$65.9 million for Q4 2025, which was up 12.73% from $66.0 million recorded in Q3 2025.
  • In the past 5 years, Incannex Healthcare's Depreciation and Depletion registered a high of $143.0 billion during Q2 2025, and its lowest value of -$66.0 million during Q4 2024.
  • For the 3-year period, Incannex Healthcare's Depreciation and Depletion averaged around $27.3 billion, with its median value being $12.0 million (2023).
  • The largest annual percentage gain for Incannex Healthcare's Depreciation and Depletion in the last 5 years was 44942.72% (2024), contrasted with its biggest fall of 26403600.0% (2024).
  • Quarter analysis of 3 years shows Incannex Healthcare's Depreciation and Depletion stood at $25000.0 in 2023, then crashed by 264036.0% to -$66.0 million in 2024, then rose by 0.13% to -$65.9 million in 2025.
  • Its Depreciation and Depletion stands at -$65.9 million for Q4 2025, versus $66.0 million for Q3 2025 and $143.0 billion for Q2 2025.